At the news
? BULLISHIMPACT 5/10 PRESS-RELEASE filed May 18, 2026 at 07:30 ET
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 blood circulation systems, following a multi-patient clinical evaluation. The order provides a key reference for ongoing strategic discussions to monetize the ART100 platform and medical assets.
- $580,000 commercial purchase order from NYU Langone Hospital for ART100 systems
- Order follows successful clinical evaluation in over 30 patients
- NYU Langone is a top-ranked academic medical center; provides strong reference for commercial discussions
- Company is engaged in an active strategic process to potentially monetize the ART100 platform and other medical assets
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access